Talazoparib plus enzalutamide in metastatic castration-resistant prostate cancer: TALAPRO-2 Phase III study design Article

cited authors

  • Agarwal, Neeraj; Azad, Arun; Shore, Neal D.; Carles, Joan; Fay, Andre P.; Dunshee, Curtis; Karsh, Lawrence Ivan; Paccagnella, Maria Luisa; Di Santo, Nicola; Elmeliegy, Mohamed; Lin, Xun; Czibere, Akos; Fizazi, Karim

authors

Publication Date

  • January 26, 2022

webpage

published in

category

keywords

  • DDR
  • PARP inhibitor
  • androgen receptor
  • enzalutamide
  • mCRPC
  • talazoparib

start page

  • 425

end page

  • 436

volume

  • 18

issue

  • 4